PATENT CLAIM ANALYSIS

Application Number: 16042917
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-02
Patent Classification: ["435", "366000"]

Abstract:
Disclosed herein are methods, compositions, kits, and agents useful for inducing β cell maturation, and isolated populations of SC-β cells for use in various applications, such as cell therapy.

Claim (Index 3):
The device of  claim 2 , wherein the non-native pancreatic \u03b2 cells exhibit an in vitro glucose-stimulated insulin secretion response to a first glucose challenge, a second glucose challenge, and a third glucose challenge, when the first glucose challenge, the second glucose challenge and the third glucose challenge are applied sequentially.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 95.0
- Lexical Diversity: 1.25
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14684101', '14975158', '15478094', '14670249', '12167227']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6212646604010775
- 35 USC 102 Novelty (BERT): 0.6478960259987327
- Combined Prediction Score: 0.6239277969608431
- Mean Citation Score: 422.614236
- Max Citation Score: 630.4137599999998
- Similarity Product: 598.245674675331

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test